Fresenius Medical Care AGFMSEarnings & Financial Report
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
FMS Q4 FY2025 Key Financial Metrics
Revenue
$5.5B
Gross Profit
$1.5B
Operating Profit
$641.4M
Net Profit
$434.2M
Gross Margin
27.4%
Operating Margin
11.7%
Net Margin
7.9%
YoY Growth
-0.3%
Fresenius Medical Care AG Q4 FY2025 Financial Summary
Fresenius Medical Care AG reported revenue of $5.5B (down 0.3% YoY) for Q4 FY2025, with a net profit of $434.2M (up 240.4% YoY) (7.9% margin). Cost of goods sold was $4.0B, operating expenses totaled $858.1M.
Key Financial Metrics
| Total Revenue | $5.5B |
|---|---|
| Net Profit | $434.2M |
| Gross Margin | 27.4% |
| Operating Margin | 11.7% |
| Report Period | Q4 FY2025 |
Fresenius Medical Care AG Quarterly Revenue & Net Profit History
Fresenius Medical Care AG results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $5.5B | -0.3% | $434.2M | 7.9% |
| Q4 FY2024 | $5.5B | +1.9% | $127.6M | 2.3% |
Income Statement
| Q4 2024 | Q4 2025 | |
|---|---|---|
| Revenue | $5.49B | $5.48B |
| YoY Growth | 1.9% | -0.3% |
Balance Sheet
| Q4 2024 | Q4 2025 | |
|---|---|---|
| Assets | $36.25B | $33.48B |
| Liabilities | $19.22B | $18.06B |
| Equity | $17.03B | $15.43B |
Cash Flow
| Q4 2024 | Q4 2025 | |
|---|---|---|
| Operating CF | $2.58B | $2.90B |